Barr Pharmaceuticals

Teligent has announced that its president and CEO, Jason Grenfell-Gardner, is stepping down immediately from the roles and leaving the firm’s board of directors after he and the board “mutually agree

Celgene Corp. 's decision to sell its blockbuster psoriasis drug Otezla (apremilast) to win US Federal Trade Commission approval of its merger with Bristol-Myers Squibb Co. surprised many investors,

As the US Federal Trade Commission begins its review of Pfizer Inc. and Mylan NV 's plan to merge Mylan with Pfizer's Upjohn off-patent branded and generic medicines business into a new company, a

Despite the US FDA's approval of two generic versions of Amgen Inc. 's Sensipar (cinacalcet), competition to the branded calcium-sensing receptor agonist may await the outcome of patent litigation